Inventor · disambiguated record
Eran Ovadia
Also filed as: OVADIA ERAN
4 granted patents·6 pending applications·9 citations·filing 2008–2024
68Inventor score
Top patents by PatentIndex Score
10 records- 0184US11852634B2Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating sameYEDA RES & DEV·Filed 2020·Granted Dec 26, 2023·1 cites·3 claims
- 0277US10747334B2Reduced keyboard disambiguating system and method thereofELAZARI AVI·Filed 2017·Granted Aug 18, 2020·7 cites·36 claims
- 0369US11912790B2Peptide compounds and therapeutic uses of sameIMMUNITY PHARMA LTD·Filed 2019·Granted Feb 27, 2024·1 cites·2 claims
- 0460US2024190919A1Peptide compounds and therapeutic uses of sameIMMUNITY PHARMA LTD·Filed 2024·Application pending·0 cites
- 0559US2019204340A1Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating sameYEDA RES & DEV·Filed 2019·Application pending·0 cites
- 0655US10288622B2Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating sameYEDA RES & DEV·Filed 2015·Granted May 14, 2019·0 cites·6 claims
- 0753US2014088017A1Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating sameUNIVERSITAETSKLINIKUM HAMBURG·Filed 2012·Application pending·0 cites
- 0842US2021100869A1Compositions and methods of using same for treating amyotrophic lateral sclerosis (als)IMMUNITY PHARMA LTD·Filed 2020·Application pending·0 cites
- 0939US2023049549A1Peptide compounds and methods of treating diseases using sameIMMUNITY PHARMA LTD·Filed 2021·Application pending·0 cites
- 1038US2011035696A1Character input system for limited keyboardsELAZARI AVI·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eran Ovadia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →